09:44 AM EST - VIVO Cannabis Inc. : Announced results from its first study investigating how medical cannabis impacts anxiety and depression outcomes. The publication is the largest study to date of its kind, examining the impact of medical cannabis using longitudinal data and completed validated questionnaires for anxiety (GAD-7) and depression (PHQ-9) in 7,362 Canadian patients. VIVO Cannabis Inc.
shares T.VIVO are trading unchanged at $0.05.
